Rapid growth in medical device testing services market

The Medical device testing services market expected to reach USD 9.00 billion by 2030.

Prospects of in-vitro and in-vivo testing methods

Explore various in vitro and in vivo testing for biocompatibility.

Secure your place

Harmonization of medical device regulations

Discover global regulatory standards standardization for devices.

View the latest program

Expert Speakers to Date

Mike Ulman
West Pharmaceutical Services
Grant Knappe
Massachussets Institute of Technology
Nick Carrara
BD
Ashwin Singhania
Ernst & Young
Joseph Kim
ProofPilot
Karthik Raman
Persist AI Formulactions Corp.
Luke Heywood
Nest Scientfic USA
Moritz Von Stosch
DataHow AG
Martin Kachele
IDT Biologika GmbH
Lan Hu
Viome Life Sciences, Inc.

Past Attendees

BD
Merck
Roche
Human Metabolome Technologies America Inc.
Massachusetts General Hospital
Moderna, Inc.
Brain Performance Center
Massachusetts Institute of Technology
Harvard University
Mayo Clinic
Seventure
University of Wisconsin
Icahn School of Medicine at Mount Sinai
CLINEXEL
Pontchartrain Cancer Center

Who should attend

Medical Device Manufactures
Biocompatibility Professionals
Clinical Affairs Specialists
Toxicology Consultants
Healthcare Consultants
Pharmaceutical Professionals
Biotechnology Professionals
Healthcare Compliance Officers
Laboratory Professionals
Regulatory Affairs
Biomedical Engineering
Logistics Professionals
Risk Management Professionals
Testing and Assessment
Quality Department
Patient Safety
Legal Professionals
Data Scientists and Analysts
Equipment Certification Services
Health Insurance
News Reporting and Journalism
Healthcare Organizations
Healthcare Service Providers
Clinical Trials Companies
Medical Device Companies
Post-Market Surveillance Companies
Medical Device Testing Companies
Biocompatibility Test Services
Healthcare IT Companies
Medical Startups and Innovators
Data Analytic Companies
Packaging and Logistics Companies
Artificial Intelligence Companies
Biotechnology Companies
R&D Scientists and Engineers
Investors and Venture Capitalists
Government Agencies
Consultants and Advisors
Public Consultation Groups
Legal and Compliance Services
News Reporters and Journalists
Patients and Patient Advocates

Why Attend

The MEDICAL DEVICE BIOCOMPATIBILITY USA 2024 exhibition and conference is the only event offering leading market intelligence and industry presentations on the latest advancements in medical device biocompatibility and clinical trials regulations to advance global healthcare.

Subscribe for updates:

The Premier Forum for Medical Device Biocompatibility and Clinical Trials Regulations

Welcome to the MEDICAL DEVICE BIOCOMPATIBILITY USA 2024 exhibition and conference, where industry leaders will meet to explore the latest advancements in medical device biocompatibility and clinical trials regulations.

Medical device manufacturers face significant challenges, including patient safety, regulatory compliance, and risk management. Learn how to navigate premarket and post-market challenges effectively, ensuring patient safety and regulatory adherence.

Join us to harness these insights optimize your strategies and lead medical device biocompatibility.

This year’s MEDICAL DEVICE BIOCOMPATIBILITY USA 2024 will become the world's leading conference and exhibition exclusively for healthcare professionals, providing a platform to meet and collaborate with medical device biocompatibility and clinical trials experts. Participants will discover innovative methods to tackle global healthcare challenges.

Key topics on this year’s agenda include:

Trends and innovations in biocompatible devices in healthcare
Assessment of medical devices using innovative testing methods
Advancing post-market surveillance of medical devices
Latest research on identifying and assessing carcinogens
Case studies on biological evaluation plans under guidance
Upcoming biocompatibility regulations in the healthcare industry

This conference and exhibition will serve as a networking forum for healthcare industry stakeholders to build cross-market relationships and address challenges in medical device biocompatibility and clinical trials regulations. It focuses on mitigating toxicological risks and enhancing compliance in medical device assessments.

Call for Presentation

If you would like to be a speaker at this event, please contact sean.collins@iQ-Hub.com with the subject heading "Call for Papers – MEDICAL DEVICE BIOCOMPATIBILITY USA 2024".

Book now

To secure your place at MEDICAL DEVICE BIOCOMPATIBILITY USA 2024, or if you require more information, please contact delegates@iQ-Hub.com.

SPONSORS / EXHIBITORS

Key topics for 2024:

Trends and innovations in biocompatible devices in healthcare
Discover the latest biocompatibility trends in the medical device lifecycle, from development to after-use.
Assessment of medical devices using innovative testing methods
Evaluate biocompatibility, functionality, safety, performance, and environmental factors using state-of-the-art testing techniques.
Advancing post-market surveillance of medical devices
Leverage cutting-edge technologies, such as artificial intelligence and data analytics, to transform the post-market surveillance of medical devices.
Latest research on identifying and assessing carcinogens
Explore research on potential carcinogens, concern cohorts, and degradation products in medical devices and assess their impact.
Case studies on biological evaluation plans under guidance
Enhance your understanding of evaluation studies to evaluate medical device compatibility with biological systems.
Upcoming biocompatibility regulations in the healthcare industry
Stay informed about emerging regulations impacting the biocompatibility of medical devices and toxicology assessments for clinical trials.